Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Recruiting 4Unknown 3Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 3Locally Advanced Pancreatic Cancer 1Gastroparesis 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 315Cyclophosphamide 295pembrolizumab 281Cisplatin 267Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 204Bevacizumab 186Gemcitabine 178venetoclax 172Radiosurgery 169Capecitabine 164Oxaliplatin 163fludarabine 161Nivolumab 156Paclitaxel 155Standard of Care 136Surveys and Questionnaires 130Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104Azacitidine 101atezolizumab 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Pancreatectomy × Clear all
NCT07396662 2026-02-09

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

National Taiwan University Hospital

Recruiting
3,500 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07382791 2026-02-03

Delayed Gastric Emptying After Pancreatic Surgery

National Taiwan University Hospital

Recruiting
3,500 enrolled
Gastrointestinal

Pancreatic Neoplasms, Gastroparesis

NCT06944587 2025-04-25

NORPACT-3

Oslo University Hospital

Recruiting
400 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡